Form 4: Waystar CEO Matthew Hawkins Exercises Options and Sells Shares in Pre-Planned Transaction
Insider Trading Report
Waystar Holding Corp.'s CEO and Director, Matthew J. Hawkins, exercised stock options and subsequently sold 59,836 shares of common stock for approximately $2.4 million in a pre-arranged transaction on June 5, 2025.
Summary
- Matthew J. Hawkins, Chief Executive Officer and Director of Waystar Holding Corp., executed a transaction on June 5, 2025.
- He acquired 59,836 shares of common stock by exercising stock options at a price of $4.14 per share.
- Immediately following the exercise, Mr. Hawkins sold all 59,836 of these shares at a weighted average price of $40.1763 per share, generating approximately $2,403,900 in proceeds.
- The sale was conducted pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-scheduled transaction not based on new, non-public information.
- After these transactions, Mr. Hawkins directly holds 764,131 shares of common stock.
- He also retains 1,272,881 directly owned stock options and 750,000 indirectly owned stock options through grantor retained annuity trusts, all with an exercise price of $4.14 and an expiration date of November 1, 2027.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the transaction is a routine exercise-and-sell of vested options, pre-planned under a 10b5-1 plan, which mitigates concerns about trading on non-public information. It also reflects the CEO realizing value from prior equity grants, which is a positive for the individual.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, which signifies a pre-scheduled sale and mitigates concerns about trading on non-public information.
- The exercise of options at $4.14 and subsequent sale at a weighted average price of $40.1763 demonstrates significant personal realization of value from previously granted equity compensation for the CEO.
Negatives
- The sale of a significant number of shares by the Chief Executive Officer, even if pre-planned, can sometimes be perceived negatively by investors as it reduces direct ownership, though this is a common practice for executive liquidity and diversification.
Risks
- While not explicitly stated as a risk, large insider sales, even when pre-planned, can occasionally lead to negative market sentiment if not fully understood by investors as part of a routine diversification or liquidity strategy.
Future Outlook
The document, a Form 4 filing, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares by a senior executive. Such transactions are common in the technology and healthcare IT sectors, where executive compensation often includes significant equity components. The pre-planned nature of the sale via a Rule 10b5-1 plan is a standard practice for executives to manage their equity holdings and diversify personal portfolios while avoiding accusations of trading on inside information.
Stakeholder Impact
- Shareholders: May observe a reduction in the CEO's direct share ownership, though the pre-planned nature of the sale under Rule 10b5-1 mitigates concerns about a lack of confidence.
- Employees: No direct impact mentioned, but executive transactions can sometimes influence morale or perception of leadership's commitment.
- Customers/Suppliers/Creditors: No direct impact from this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 06/05/2025 | Date of stock option exercise and subsequent sale of common stock by Matthew J. Hawkins. |
| 06/06/2025 | Date the Form 4 was signed by Gregory R. Packer as Attorney-in-Fact for Matthew J. Hawkins. |
| 11/01/2027 | Expiration date for the reported stock options. |
Recommendation
holdKeywords
Waystar Holding Corp., WAY, SEC Form 4, Insider Trading, Stock Options, Share Sale, Matthew J. Hawkins, CEO, Director, Equity Compensation, Rule 10b5-1, Public Company Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.